FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gema Moreno-Bueno

Research Profile

Disorders

Physiology

Anatomy

Tumor Cell Line

Chemicals & Drugs

Procedures

Devices

Oligonucleotide Array Sequence Analysis

Co-author Network

Publications

TOP 3
Laura Romero-Pérez; Jaime Prat; Susana Ramiro-Fuentes; Michele Biscuola; Amparo Cano; María Ángeles Castilla; Juan Díaz-Martín; María Ángeles López-García; Xavier Matias-Guiu; Gema Moreno-Bueno; Esther Oliva; José Palacios
Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis.
A Yeramian; Miguel Abal; Lluis Catasus; E Colas; Xavier Dolcet; Gema Moreno-Bueno; J Palacios; Jaime Prat; Jaume Reventos; Xavier Matias-Guiu
Endometrial carcinoma: molecular alterations involved in tumor development and progression.
Eva Cubillo; Eva P Cuevas; Antonio Diaz-Lopez; Amalia Montes; Gema Moreno-Bueno; Héctor Peinado; Francisco Portillo; Vanesa Santos; Amparo Cano
E47 and id1 interplay in epithelial-mesenchymal transition.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gema Moreno-Bueno (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Laura Romero-Pérez; Jaime Prat; Susana Ramiro-Fuentes; Michele Biscuola; Amparo Cano; María Ángeles Castilla; Juan Díaz-Martín; María Ángeles López-García; Xavier Matias-Guiu; Gema Moreno-Bueno; Esther Oliva; José Palacios
Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis.
Human pathology 2013;44(2):244-54.
2013: A Yeramian; Miguel Abal; Lluis Catasus; E Colas; Xavier Dolcet; Gema Moreno-Bueno; J Palacios; Jaime Prat; Jaume Reventos; Xavier Matias-Guiu
Endometrial carcinoma: molecular alterations involved in tumor development and progression.
Oncogene 2013;32(4):403-13.
2013: Eva Cubillo; Eva P Cuevas; Antonio Diaz-Lopez; Amalia Montes; Gema Moreno-Bueno; Héctor Peinado; Francisco Portillo; Vanesa Santos; Amparo Cano
E47 and id1 interplay in epithelial-mesenchymal transition.
PloS one 2013;8(3):e59948.
2012: Oscar H Ocaña; Sonia Vega; Hervé Acloque; Alejandro Barrallo-Gimeno; Amparo Cano; Rebeca Córcoles; Angels Fabra; Gema Moreno-Bueno; M Angela Nieto
Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.
Cancer cell 2012;22(6):709-24.
2012: Eva Colas; Laura Devis; Xavier Dolcet; Andreas Doll; Tugçe Ertekin; Angel Garcia; Marta Garcia; Antonio Gil-Moreno; Marta Llauradó; Elena Martínez; Xavier Matias-Guiu; Gema Moreno-Bueno; Mireia Olivan; Jose Palacios; Nuria Pedrola; Jaime Prat; Santiago Ramon Y Cajal; Miguel Abal; Francesc Alameda; Silvia Cabrera; Irene Campoy; Josep Castellvi; Marina Rigau; Jordi Xercavins; Jaume Reventos
The EMT signaling pathways in endometrial carcinoma.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2012;14(10):715-20.
2012: Amparo Cano; Patricia G Santamaría; Gema Moreno-Bueno
LOXL2 in epithelial cell plasticity and tumor progression.
Future oncology (London, England) 2012;8(9):1095-108.
2012: Héctor Peinado; Johan Skog; Caitlin Williams; Jedd D Wolchok; Jianda Yuan; Maša Alečković; Vilma R Martins; Irina Matei; Gema Moreno-Bueno; Ayuko Nitadori-Hoshino; Karen Badal; Mary S Brady; Jacqueline F Bromberg; Margaret K Callahan; Paul B Chapman; Bruno Costa-Silva; Benjamin A Garcia; Guillermo García-Santos; Cyrus Ghajar; Marta Hergueta-Redondo; Caitlin Hoffman; Yibin Kang; Rosandra N Kaplan; Simon Lavotshkin; David Lyden
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.
Nature medicine 2012;18(6):883-91.
2012: mario duran-prado; Manuel D Gahete; Francisco Gracia-Navarro; M Hergueta-Redondo; Raul M Luque; María M Malagón; Antonio J Martínez-Fuentes; Gema Moreno-Bueno; J Palacios; J Córdoba-Chacón; Justo P Castaño
The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells.
Oncogene 2012;31(16):2049-61.
2011: Gema Moreno-Bueno; José Palacios; Héctor Peinado; Francisco Portillo; Alejandro Rojo-Sebastián; Fernando Salvador; Vanesa Santos; Maria Angeles Castilla; Katalin Csiszar; Eva P Cuevas; Alfredo Floristán; David Hardisson; Alberto Martín; Alejandra Martínez; Amalia Montes; Saleta Morales; Amparo Cano
Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas.
EMBO molecular medicine 2011;3(9):528-44.
2011: David Llobet; Nuria Eritja; Monica Domingo; Laura Bergada; Cristina Mirantes; Maria Santacana; Judit Pallares; Anna Macià; Andree Yeramian; Mario Encinas; Gema Moreno-Bueno; Jose Palacios; Robert E Lewis; Xavier Matias-Guiu; Xavier Dolcet
KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels.
The American journal of pathology 2011;178(4):1529-43.
2011: María Abad; Alberto Moreno; Alicia Palacios; Masako Narita; Francisco Jose Blanco; Gema Moreno-Bueno; Masashi Narita; Ignacio Palmero
The tumor suppressor ING1 contributes to epigenetic control of cellular senescence.
Aging cell 2011;10(1):158-71.
2011: Manuel D Gahete; Marta Hergueta-Redondo; Rhonda D Kineman; Raul M Luque; Antonio J Martínez-Fuentes; Gema Moreno-Bueno; José Córdoba-Chacón; Justo P Castaño
A novel human ghrelin variant (In1-ghrelin) and ghrelin-O-acyltransferase are overexpressed in breast cancer: potential pathophysiological relevance.
PloS one 2011;6(8):e23302.
2011: María Ángeles Castilla; Gema Moreno-Bueno; Laura Romero-Pérez; Koen Van De Vijver; Michele Biscuola; María Ángeles López-García; Jaime Prat; Xavier Matías-Guiu; Amparo Cano; Esther Oliva; José Palacios
Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma.
The Journal of pathology 2011;223(1):72-80.
2010: María Caffarel; Clara Andradas; Emilia Mira; Eduardo Pérez-Gómez; Camilla Cerutti; Gema Moreno-Bueno; Juana M Flores; Isabel García-Real; José Palacios; Santos Mañes; Manuel Guzmán; Cristina Sánchez
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.
Molecular cancer 2010;9():196.
2009: Pablo J Fernandez-Marcos; Shadi Abu-Baker; Jayashree Joshi; Anita Galvez; Elias A Castilla; Marta Cañamero; Manuel Collado; Carmen Saez; Gema Moreno-Bueno; Jose Palacios; Michael Leitges; Manuel Serrano; Jorge Moscat; María T Diaz-Meco
Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-kappaB activation and invasive prostate carcinoma.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(31):12962-7.
2009: Julia Turbiner Geyer; Maria Angeles López-García; Carolina Sánchez-Estevez; David Sarrió; Gema Moreno-Bueno; Ilaria Franceschetti; José Palacios; Esther Oliva
Pathogenetic pathways in ovarian endometrioid adenocarcinoma: a molecular study of 29 cases.
The American journal of surgical pathology 2009;33(8):1157-63.
2009: Rachael Natrajan; Maryou B K Lambros; Socorro María Rodríguez-Pinilla; Gema Moreno-Bueno; David S P Tan; Caterina Marchió; Radost Vatcheva; Sydonia Rayter; Betania Mahler-Araujo; Laura G Fulford; Daniela Hungermann; Alan Mackay; Anita Grigoriadis; Kerry Fenwick; Narinder Tamber; David Hardisson; Andrew Tutt; José Palacios; christopher Lord; Horst Buerger; Alan Ashworth; Jorge S Reis-Filho
Tiling path genomic profiling of grade 3 invasive ductal breast cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(8):2711-22.
2009: Veronica Romina Sobrado; Gema Moreno-Bueno; Eva Cubillo; Liam J Holt; Angela Nieto; Francisco Portillo; Amparo Cano
The class I bHLH factors E2-2A and E2-2B regulate EMT.
Journal of cell science 2009;122(Pt 7):1014-24.
2009: Gema Moreno-Bueno; Héctor Peinado; Patricia Molina; David Olmeda; Eva Cubillo; Vanesa Santos; José Palacios; Francisco Portillo; Amparo Cano
The morphological and molecular features of the epithelial-to-mesenchymal transition.
Nature protocols 2009;4(11):1591-613.
2009: David Sarrió; José Palacios; Marta Hergueta-Redondo; Gonzalo Gómez-López; Amparo Cano; Gema Moreno-Bueno
Functional characterization of E- and P-cadherin in invasive breast cancer cells.
BMC cancer 2009;9():74.
2008: Gema Moreno-Bueno; F Portillo; Amparo Cano
Transcriptional regulation of cell polarity in EMT and cancer.
Oncogene 2008;27(55):6958-69.
2008: Ma Carmen Durán; Francisco Vega; Gema Moreno-Bueno; Ma Jesus Artiga; Lydia Sanchez; Jose Palacios; Anne Ridley; John Francis Timms
Characterisation of tumoral markers correlated with ErbB2 (HER2/Neu) overexpression and metastasis in breast cancer.
Proteomics. Clinical applications 2008;2(9):1313-26.
2008: Julia Turbiner; Gema Moreno-Bueno; Sonika Dahiya; Carolina Sánchez-Estevez; David Hardisson; Jaime Prat; Esther Oliva; José Palacios
Clinicopathological and molecular analysis of endometrial carcinoma associated with tamoxifen.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(8):925-36.
2008: Héctor Peinado; Gema Moreno-Bueno; David Hardisson; Eduardo Pérez-Gómez; Vanesa Santos; Marta Mendiola; Juan Ignacio De Diego; Manuel Nistal; Miguel Quintanilla; Francisco Portillo; Amparo Cano
Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas.
Cancer research 2008;68(12):4541-50.
2008: David Sarrió; Socorro María Rodriguez-Pinilla; David Hardisson; Amparo Cano; Gema Moreno-Bueno; José Palacios
Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype.
Cancer research 2008;68(4):989-97.
2008: Elizabeth Fabre-Guillevin; Michel Malo; Amandine Cartier-Michaud; Hector Peinado; Gema Moreno-Bueno; Benoît Vallée; Daniel Lawrence; José Palacios; Amparo Cano; Georgia Barlovatz-Meimon; Cécile Charrière-Bertrand
PAI-1 and functional blockade of SNAI1 in breast cancer cell migration.
Breast cancer research : BCR 2008;10(6):R100.
2007: David Olmeda; Gema Moreno-Bueno; Juana M Flores; Angels Fabra; Francisco Portillo; Amparo Cano
SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells.
Cancer research 2007;67(24):11721-31.
2007: Héctor Hernández-Vargas; Cayetano von Kobbe; Carolina Sánchez-Estévez; Mercedes Julián-Tendero; José Palacios; Gema Moreno-Bueno
Inhibition of paclitaxel-induced proteasome activation influences paclitaxel cytotoxicity in breast cancer cells in a sequence-dependent manner.
Cell cycle (Georgetown, Tex.) 2007;6(21):2662-8.
2007: Socorro María Rodríguez-Pinilla; David Sarrió; Emiliano Honrado; Gema Moreno-Bueno; David Hardisson; Francisco Calero; Javier Benítez; José Palacios
Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas.
Journal of clinical pathology 2007;60(9):1006-12.
2007: Héctor Hernández-Vargas; José Palacios; Gema Moreno-Bueno
Molecular profiling of docetaxel cytotoxicity in breast cancer cells: uncoupling of aberrant mitosis and apoptosis.
Oncogene 2007;26(20):2902-13.
2007: Socorro María Rodríguez-Pinilla; Yolanda Rodríguez-Gil; Gema Moreno-Bueno; David Sarrió; M Del Carmen Martín-Guijarro; Lucía Hernandez; José Palacios
Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: an immunohistochemical and gene amplification study.
The American journal of surgical pathology 2007;31(4):501-8.
2007: Héctor Hernández-Vargas; José Palacios; Gema Moreno-Bueno
Telling cells how to die: docetaxel therapy in cancer cell lines.
Cell cycle (Georgetown, Tex.) 2007;6(7):780-3.
2007: Socorro M Rodriguez-Pinilla; David Sarrio; Gema Moreno-Bueno; Yolanda Rodriguez-Gil; Miguel A Martinez; Lucia Hernandez; David Hardisson; Jorge S Reis-Filho; José Palacios
Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(4):474-81.
2007: Héctor Hernández-Vargas; Socorro María Rodríguez-Pinilla; Mercedes Julián-Tendero; Pedro Sánchez-Rovira; Cristóbal Cuevas; Antonio Antón; Maria Jesus Ríos; José Palacios; Gema Moreno-Bueno
Gene expression profiling of breast cancer cells in response to gemcitabine: NF-kappaB pathway activation as a potential mechanism of resistance.
Breast cancer research and treatment 2007;102(2):157-72.
2007: Gema Moreno-Bueno; Pablo J Fernandez-Marcos; Manuel Collado; Mercedes J Tendero; Socorro M Rodriguez-Pinilla; Isabel Garcia-Cao; David Hardisson; María T Diaz-Meco; Jorge Moscat; Manuel Serrano; José Palacios
Inactivation of the candidate tumor suppressor par-4 in endometrial cancer.
Cancer research 2007;67(5):1927-34.
2006: Míriam Molina-Arcas; Gema Moreno-Bueno; Pedro Cano-Soldado; Héctor Hernández-Vargas; F Javier Casado; José Palacios; Marçal Pastor-Anglada
Human equilibrative nucleoside transporter-1 (hENT1) is required for the transcriptomic response of the nucleoside-derived drug 5'-DFUR in breast cancer MCF7 cells.
Biochemical pharmacology 2006;72(12):1646-56.
2006: Gema Moreno-Bueno; Eva Cubillo; David Sarrió; Héctor Peinado; Socorro María Rodríguez-Pinilla; Sonia Villa; Victoria Bolós; Mireia Jordá; Angels Fabra; Francisco Portillo; José Palacios; Amparo Cano
Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition.
Cancer research 2006;66(19):9543-56.
2006: Héctor Hernández-Vargas; Esteban Ballestar; PEdro Carmona-Saez; Cayetano von Kobbe; Inmaculada Bañón-Rodríguez; Manel Esteller; Gema Moreno-Bueno; José Palacios
Transcriptional profiling of MCF7 breast cancer cells in response to 5-Fluorouracil: relationship with cell cycle changes and apoptosis, and identification of novel targets of p53.
International journal of cancer. Journal international du cancer 2006;119(5):1164-75.
2006: David Sarrió; Gema Moreno-Bueno; Carolina Sánchez-Estévez; Inmaculada Bañón-Rodríguez; Ginés Hernández-Cortés; David Hardisson; José Palacios
Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.
Human pathology 2006;37(8):1042-9.
2006: Gema Moreno-Bueno; Carolina Sanchez-Estevez; José Palacios; David Hardisson; Tanri Shiozawa
Low frequency of BRAF mutations in endometrial and in cervical carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(12):3865; author reply 3865-6.
2006: Esther Oliva; David Sarrió; Elena F Brachtel; Carolina Sánchez-Estévez; Robert A Soslow; Gema Moreno-Bueno; José Palacios
High frequency of beta-catenin mutations in borderline endometrioid tumours of the ovary.
The Journal of pathology 2006;208(5):708-13.
2005: Elena F Brachtel; Carolina Sánchez-Estevez; Gema Moreno-Bueno; Jaime Prat; José Palacios; Esther Oliva
Distinct molecular alterations in complex endometrial hyperplasia (CEH) with and without immature squamous metaplasia (squamous morules).
The American journal of surgical pathology 2005;29(10):1322-9.
2004: Pablo Matar; Federico Rojo; Raúl Cassia; Gema Moreno-Bueno; Serena Di Cosimo; Josep Tabernero; Marta Guzmán; Sonia Rodriguez; Joaquín Arribas; José Palacios; José Baselga
Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(19):6487-501.
2004: Gema Moreno-Bueno; Sandra Rodríguez-Perales; Carolina Sánchez-Estévez; Raquel Marcos; David Hardisson; Juan C Cigudosa; José Palacios
Molecular alterations associated with cyclin D1 overexpression in endometrial cancer.
International journal of cancer. Journal international du cancer 2004;110(2):194-200.
2004: David Sarrió; Belén Pérez Mies; David Hardisson; Gema Moreno-Bueno; Asunción Suárez; Amparo Cano; Jorge Martín-Pérez; Carlos Gamallo; José Palacios
Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions.
Oncogene 2004;23(19):3272-83.
2004: Gema Moreno-Bueno; David Hardisson; J Prat; J Matías-Guiu; J Palacios
Re: Scholten et al. Nuclear beta-catenin is a molecular feature of type I endometrial carcinoma. J Pathol 2003; 201: 460-465.
The Journal of pathology 2004;202(4):511-2.
2003: Raúl Cassia; Gema Moreno-Bueno; Sandra Rodríguez-Perales; David Hardisson; Juan C Cigudosa; José Palacios
Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma.
The Journal of pathology 2003;201(4):589-95.
2003: David Hardisson; Gema Moreno-Bueno; Lydia Sánchez; David Sarrió; Asunción Suárez; Francisco Calero; José Palacios
Tissue microarray immunohistochemical expression analysis of mismatch repair (hMLH1 and hMSH2 genes) in endometrial carcinoma and atypical endometrial hyperplasia: relationship with microsatellite instability.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2003;16(11):1148-58.
2003: Gema Moreno-Bueno; Carolina Sánchez-Estévez; Raúl Cassia; Sandra Rodríguez-Perales; Ramón Díaz-Uriarte; Orlando Domínguez; David Hardisson; Miguel Andujar; Jaime Prat; Xavier Matias-Guiu; Juan C Cigudosa; José Palacios
Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas.
Cancer research 2003;63(18):5697-702.
2003: Gema Moreno-Bueno; Sandra Rodríguez-Perales; Carolina Sánchez-Estévez; David Hardisson; David Sarrió; Jaime Prat; Juan C Cigudosa; Xavier Matias-Guiu; José Palacios
Cyclin D1 gene (CCND1) mutations in endometrial cancer.
Oncogene 2003;22(38):6115-8.
2003: David Sarrió; Gema Moreno-Bueno; David Hardisson; Carolina Sánchez-Estévez; Mingzhou Guo; James G Herman; Carlos Gamallo; Manel Esteller; José Palacios
Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability.
International journal of cancer. Journal international du cancer 2003;106(2):208-15.
2003: Gema Moreno-Bueno; David Hardisson; David Sarrió; Carolina Sánchez; Raúl Cassia; Jaime Prat; James G Herman; Manel Esteller; Xavier Matías-Guiu; José Palacios
Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia.
The Journal of pathology 2003;199(4):471-8.
2002: Gema Moreno-Bueno; David Hardisson; Carolina Sánchez; David Sarrió; Raúl Cassia; Ginesa García-Rostán; Jaime Prat; Mingzhou Guo; James G Herman; Xavier Matías-Guiu; Manel Esteller; José Palacios
Abnormalities of the APC/beta-catenin pathway in endometrial cancer.
Oncogene 2002;21(52):7981-90.
2002: Maria J Blanco; Gema Moreno-Bueno; David Sarrio; Annamaria Locascio; Amparo Cano; José Palacios; M Angela Nieto
Correlation of Snail expression with histological grade and lymph node status in breast carcinomas.
Oncogene 2002;21(20):3241-6.
2001: Esther Gras; Lluis Catasus; R Argüelles; Gema Moreno-Bueno; J Palacios; Carlos Gamallo; Xavier Matias-Guiu; Jaime Prat
Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors.
Cancer 2001;92(11):2829-36.
2001: Gema Moreno-Bueno; Carlos Gamallo; L Pérez-Gallego; F Contreras; José Palacios
beta-catenin expression in pilomatrixomas. Relationship with beta-catenin gene mutations and comparison with beta-catenin expression in normal hair follicles.
The British journal of dermatology 2001;145(4):576-81.
2001: Carlos Gamallo; Gema Moreno-Bueno; David Sarrió; Francisco Calero; David Hardisson; José Palacios
The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2001;14(7):650-4.
2001: L Pérez-Gallego; Gema Moreno-Bueno; David Sarrió; A Suárez; C Gamallo; J Palacios
Human papillomavirus-16 E6 variants in cervical squamous intraepithelial lesions from HIV-negative and HIV-positive women.
American journal of clinical pathology 2001;116(1):143-8.
2001: Gema Moreno-Bueno; Carlos Gamallo; L Pérez-Gallego; J C de Mora; A Suárez; José Palacios
beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2001;10(2):116-22.
2001: José Palacios; Lluis Catasús; Gema Moreno-Bueno; Xavier Matias-Guiu; Jaime Prat; Carlos Gamallo
Beta- and gamma-catenin expression in endometrial carcinoma. Relationship with clinicopathological features and microsatellite instability.
Virchows Archiv : an international journal of pathology 2001;438(5):464-9.
2000: Javier De Castro; Carlos Gamallo; J Palacios; Gema Moreno-Bueno; N Rodríguez; Jaime Feliu; Manuel González Barón
beta-catenin expression pattern in primary oesophageal squamous cell carcinoma. Relationship with clinicopathologic features and clinical outcome.
Virchows Archiv : an international journal of pathology 2000;437(6):599-604.